VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

被引:559
作者
Gerber, HP
Malik, AK
Solar, GP
Sherman, D
Liang, XH
Meng, G
Hong, K
Marsters, JC
Ferrara, N
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Assay Dev, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Organ Chem, San Francisco, CA 94080 USA
基金
英国惠康基金;
关键词
D O I
10.1038/nature00821
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vascular endothelial growth factor (VEGF) is a principal regulator of blood vessel formation and haematopoiesis(1,2), but the mechanisms by which VEGF differentially regulates these processes have been elusive. Here we describe a regulatory loop by which VEGF controls survival of haematopoietic stem cells (HSCs). We observed a reduction in survival, colony formation and in vivo repopulation rates of HSCs after ablation of the VEGF gene in mice. Intracellularly acting small-molecule inhibitors of VEGF receptor (VEGFR) tyrosine kinase dramatically reduced colony formation of HSCs, thus mimicking deletion of the VEGF gene. However, blocking VEGF by administering a soluble VEGFR-1, which acts extracellularly, induced only minor effects. These findings support the involvement in HSC survival of a VEGF-dependent internal autocrine loop mechanism (that is, the mechanism is resistant to inhibitors that fail to penetrate the intracellular compartment). Not only ligands selective for VEGF and VEGFR-2 but also VEGFR-1 agonists rescued survival and repopulation of VEGF-deficient HSCs, revealing a function for VEGFR-1 signalling during haematopoiesis.
引用
收藏
页码:954 / 958
页数:6
相关论文
共 30 条
[1]   A role for the Wnt gene family in hematopoiesis: Expansion of multilineage progenitor cells [J].
Austin, TW ;
Solar, GP ;
Ziegler, FC ;
Liem, L ;
Matthews, W .
BLOOD, 1997, 89 (10) :3624-3635
[2]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]   Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells:: Possible role in the hematopoietic microenvironment [J].
Bautz, F ;
Rafii, S ;
Kanz, L ;
Möhle, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :700-706
[4]   Cytokine and chemokine production by CD34(+) haemopoietic progenitor cells: Detection in single cells [J].
Behringer, D ;
Kresin, V ;
Henschler, R ;
Mertelsmann, R ;
Lindemann, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (01) :9-14
[5]   Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes [J].
Bellamy, WT ;
Richter, L ;
Sirjani, D ;
Roxas, C ;
Glinsmann-Gibson, B ;
Frutiger, Y ;
Grogan, TM ;
List, AF .
BLOOD, 2001, 97 (05) :1427-1434
[6]   MECHANISM OF AUTOCRINE STIMULATION IN HEMATOPOIETIC-CELLS PRODUCING INTERLEUKIN-3 AFTER RETROVIRUS-MEDIATED GENE-TRANSFER [J].
BROWDER, TM ;
ABRAMS, JS ;
WONG, PMC ;
NIENHUIS, AW .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (01) :204-213
[7]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[8]   Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias [J].
Dias, S ;
Hattori, K ;
Heissig, B ;
Zhu, ZP ;
Wu, Y ;
Witte, L ;
Hicklin, DJ ;
Tateno, M ;
Bohlen, P ;
Moore, MAS ;
Rafii, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10857-10862
[9]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[10]   Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia [J].
Fiedler, W ;
Graeven, U ;
Ergun, S ;
Verago, S ;
Kilic, N ;
Stockschlader, M ;
Hossfeld, DK .
BLOOD, 1997, 89 (06) :1870-1875